FDA may approve implantable drug to ease opiod withdrawal
May 02, 2016 at 12:05 PM EDT
Probupine, the implantable version of buprenorphine could significantly expand use of that medication, which prevents withdrawal symptoms in addicts.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.